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CME: Peripheral vascular disease
This month’s education component deals with peripheral vascular 
disease. A review article presents the evidence for and against 
novel anticoagulants,[1] the use of which was detailed in ‘Venous 
thromboembolism: Prophylactic and therapeutic practice guideline’. [2] 
We include summaries of full articles (available online), which consider:
• the clinical screening for peripheral arterial disease,[3] important 
because its presence signals future cerebrovascular complications 
and premature mortality
• the spectrum of chronic venous disorders – which, with a 
prevalence of 5 - 30% in adults, impact significantly on health and 
wellbeing – and its clinical and radiological diagnosis.[4]
Palliative care needs in South Africa
Two articles[5,6] and two editorials[7,8] address the palliative care needs 
in South Africa (SA), and Africa more widely.
Van Niekerk and Raubenheimer[5] address the particular needs of 
patients with severe chronic medical illness … ‘the greatest burden 
of disease was found in the general medical wards’. Their survey 
found that the inpatient mortality of medical patients admitted to the 
general medical service was 11%, with a 12-month post-discharge 
mortality of 35%. In many cases this was predictable on discharge, 
reflecting the burden of patients requiring palliative care in the acute 
medical service. 
Farrant et al.[6] describe palliative care needs in HIV-positive 
patients receiving highly active antiretroviral therapy (HAART). The 
authors found a high symptom burden despite patients receiving 
treatment, and recommend that detailed symptom assessment and 
control should be part of HIV care to address palliative care in HIV 
alongside HAART, as is well established in the UK.
A notable finding regarding medical patients was their much 
younger average age compared with international samples reflecting 
the burden of disease in patients with non-communicable diseases, 
cancer and HIV/AIDS.[5] In addition, resource constraints result in 
patients requiring palliative care for conditions (e.g. end-stage renal 
failure) that would be treatable in better-resourced settings. 
The need for palliative care is increasing globally, but is especially 
critical in developing countries. Of the 58 million annual deaths in 
2008, 45 million occurred in developing countries, with the World 
Health Organization (WHO) estimating that approximately 10 
million people are in need of palliative care across Africa.
Providing palliative care to patients not only relieves symptoms 
and improves patient satisfaction, but may also reduce admission 
rates and length of hospital stay and decrease the overall cost of care. 
Failing to numb the pain:  
The untreated epidemic
An editorial by Powell et al.[7] highlights the consensus statement 
arising out of the first session of the African Ministers of Health 
on palliative care, held in September 2013 at the joint conference 
of the African Palliative Care Association/Hospice and Palliative 
Care Association of South Africa in Johannesburg, that proposed ‘... 
the use of the already established global and regional frameworks 
provided by the African Union and WHO, to ensure availability 
of, and access to, essential medicines and technologies for the 
treatment of pain and other symptoms being experienced by so 
many in Africa, including children. This includes the procurement 
and distribution of morphine, to ensure greater availability and 
access of this main opioid for the management of moderate to 
severe pain’. This was in response to the reality that no one African 
country has all seven of the formulations considered essential for the 
relief of cancer pain (i.e. codeine, immediate and slow-release oral 
morphine, injectable morphine, oral oxycodone, oral methadone and 
transdermal fentanyl).
Hidden costs of alcohol-related harms
Matzopoulos et al.[9] unpack, in impressive detail, the economic, 
social and health costs associated with alcohol-related harms to 
inform alcohol management policies and laws. The combined total 
tangible and intangible costs of alcohol harm to the economy were 
estimated at 10 - 12% of (the 2009) gross domestic product. The 
impact on health is huge: alcohol is the third-largest contributor to 
death and disability after unsafe sex/sexually-transmitted infections 
and interpersonal violence, both of which are themselves influenced 
by alcohol consumption. 
The pros and cons of alcohol advertising have been much in 
the news. Given the prevalence and magnitude of drinking in SA, 
companies on the supply side of the alcohol market are powerful 
and their economic influence means that the existing frameworks 
that guide the regulation and distribution of alcohol are founded on 
claims of their contributions to the local economy. The authors assert 
that these industry claims must be assessed against the economic, 
social and health costs associated with the end use of their products. 
Furthermore, consideration should be given to who is benefiting 
from the industry and who is paying its costs.
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